AI that clears the FDA, ships to customers, and pays for itself.
I’m Mohammad Haft-Javaherian. I led machine learning for SKOUT, an FDA-cleared AI colonoscopy device, and built a 28-person ML organization. Now I bring that leadership to companies that need AI to work in the real world, without a full-time executive hire.
Built for teams where AI has to be right.
Medtech & digital health startups. From AI roadmap to clinical validation to an FDA-ready model.
Established companies adopting AI. Finding the use cases that move the P&L, then shipping the first one.
Pharma & life-science teams. AI endpoints, trial screening, and data partnerships delivered on budget.
Ways to work together
Fractional Head of AI. A seat next to your CEO: strategy, roadmap, hiring, and technical oversight.
AI Roadmap, 4 weeks. Find and rank your highest-ROI AI opportunities, with a plan your board can approve.
Proof of Concept, 8 weeks. Build the top use case end to end and measure it against a real baseline.
Technical Due Diligence. For investors: an independent read on an AI or medtech company’s team, data, models, and regulatory path.
Hourly advisory starts at $350/hour. Larger engagements are quoted as fixed fees after a scoping call.
Results, not slideware.
$1.4M bottom-line impact. A quality-assurance prediction model for an 8-figure US manufacturer.
700% faster clinical-trial screening. An LLM multi-agent system over EHRs, at about 2.5% error.
27% more adenomas found per colonoscopy. SKOUT, an AI device taken through multiple FDA 510(k) clearances.
+18.5% enrollment, +22% revenue. As fractional Chief Strategy Officer for an education institute.
Have an AI decision on the table?
Tell me where you are. In 30 minutes we’ll figure out whether AI is the right move, what it should cost, and what to do first.